News on research and diagnostics for metabolic disorders and metabolic diseases.
The team used genetic scoring to identify infants without a family history of the disease who had more than a 10 percent risk for developing islet antibodies.
ReviveMed's technology uses artificial intelligence-based analysis of metabolomics data for drug discovery and development.
Using data for thousands of Chinese individuals, researchers saw new and known variants associated with type 2 diabetes, fasting glucose levels, and other metabolic traits.
The funding will support further development of an existing serum-based assay and expansion of the test to use saliva samples.
Two papers in Nature Genetics found that loss-of-function variants in ADCY3 were associated with severe obesity, and that ADCY3 could be a treatment target.
